Preliminary scientific studies reveal conolidine may inhibit certain ion channels, reducing neuronal excitability and restricting discomfort indicators. This system is particularly relevant in neuropathic ache, where abnormal signaling leads to persistent soreness. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pathways